UK markets open in 7 hours 30 minutes

Axsome Therapeutics, Inc. (AXSM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
74.89+1.13 (+1.53%)
At close: 04:00PM EDT
74.84 -0.05 (-0.07%)
After hours: 06:52PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts15141613
Avg. Estimate-1.2-1.01-3.781.23
Low estimate-1.45-1.26-5.02-2.51
High estimate-0.98-0.75-24.9
Year ago EPS-0.26-1.54-5.27-3.78
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts14141615
Avg. Estimate73.29M87.44M375.48M697.06M
Low estimate65.7M80.5M343.85M538.95M
High estimate84.76M95M442.8M942.55M
Year ago sales26.07M40.93M270.6M375.48M
Sales growth (year/est)181.10%113.60%38.80%85.60%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-1.04-1.22-1.2-1.17
Actual EPS-0.26-1.54-1.32-2.08
Difference0.78-0.32-0.12-0.91
Surprise %75.00%-26.20%-10.00%-77.80%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-1.2-1.01-3.781.23
7 days ago-1.18-1-3.771.13
30 days ago-1.18-1.01-3.790.99
60 days ago-1.2-1.04-3.770.57
90 days ago-1.1-0.93-3.171.73
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/A1N/AN/A
Up last 30 days2222
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1N/A22
Growth estimatesAXSMIndustrySector(s)S&P 500
Current qtr.-361.50%N/AN/AN/A
Next qtr.34.40%N/AN/AN/A
Current year28.30%N/AN/AN/A
Next year132.50%N/AN/AN/A
Next 5 years (per annum)187.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A